KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to 0.09%.

  • AbbVie's Return on Capital Employed fell 400.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.09% for FY2024, which is 300.0% down from last year.
  • According to the latest figures from Q3 2025, AbbVie's Return on Capital Employed is 0.09%, which was down 400.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, AbbVie's Return on Capital Employed ranged from a high of 0.17% in Q2 2023 and a low of 0.09% during Q4 2024
  • Moreover, its 5-year median value for Return on Capital Employed was 0.14% (2021), whereas its average is 0.13%.
  • Within the past 5 years, the most significant YoY rise in AbbVie's Return on Capital Employed was 700bps (2021), while the steepest drop was -800bps (2021).
  • Over the past 5 years, AbbVie's Return on Capital Employed (Quarter) stood at 0.16% in 2021, then rose by 3bps to 0.16% in 2022, then fell by -20bps to 0.13% in 2023, then crashed by -30bps to 0.09% in 2024, then rose by 3bps to 0.09% in 2025.
  • Its last three reported values are 0.09% in Q3 2025, 0.11% for Q2 2025, and 0.1% during Q1 2025.